Core Laboratories NV (NYSE: CLB) has reported E.P.S. of $0.15 for its fourth fiscal quarter (ending December 31) versus $0.05 for the same period a year ago — an increase of 200%. For the latest four quarters through December 31, E.P.S. were $0.66 compared to $0.79 a year ago — a decline of -16%.
Recent Price Action
Core Laboratories NV (NYSE: CLB) stock rose slightly by 0.05% on 1/29/25. The stock closed at $18.54. Moreover, this advance was accompanied by above average trading volume at 125% of normal. The stock has performed in line with the market over the last nine months and has declined -8.8% during the last week.
Current PriceTarget Research Rating
Core Laboratories has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Core Laboratories has a slightly negative Power Rating of 35 and a poor Appreciation Score of 17, and the Lowest Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment